What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 1 minute read Pharma Industry News Cellectis begins MELANI-01 clinical trial for UCARTCS1 in multiple myeloma Cellectis said that it has dosed the first patient in a phase 1 study – the MELANI-01 clinical… bypharmanewsdailyOctober 30, 2019
